Establishing a Decision-Making Threshold for PIVKA II in the Diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC): A Single Centre Experience
This study establishes a novel cut-off for PIVKA II in PDAC, supporting its utility as a biomarker. Further research is needed to validate these findings across diverse populations.
Authors
- Valentina Viggiani
- Antonella Farina (ORCID: https://orcid.org/0000-0002-8629-0971)
- Antonio Angeloni (ORCID: https://orcid.org/0000-0003-4969-9548)
- Emanuela Anastasi (ORCID: https://orcid.org/0000-0002-5124-3219)
- Sara Tartaglione (ORCID: https://orcid.org/0000-0003-0934-4064)
- Isabella Oliviero
Institutions
- Policlinico Umberto I (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Asian Pacific Journal of Cancer Prevention
- Published
- 2025-10-01
- DOI
- https://doi.org/10.31557/apjcp.2025.26.10.3603
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00